Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Ravindran

Showing results (221-230 of 252) with videos related to

Pageof 26
Sort By:
Psychiatry Research|May 10, 2023
The course of insomnia symptoms during the acute treatment of major depressive disorder: A CAN-BIND-1 reportManish Dama, Michelle Wu, Vanessa K Tassone, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 4, 2016
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 1. Disease Burden and Principles of CareRaymond W Lam, Diane McIntosh, JianLi Wang, et al.
Brain and Behavior|March 25, 2022
Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapyCaroline W Espinola, Yuelee Khoo, Roohie Parmar, et al.
BMJ Open|August 13, 2017
Comparative efficacy and acceptability of antidepressants, psychological interventions, and their combination for depressive disorder in children and adolescents: protocol for a network meta-analysisXinyu Zhou, Andrea Cipriani, Yuqing Zhang, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 4, 2016
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation TreatmentsRoumen V Milev, Peter Giacobbe, Sidney H Kennedy, et al.
Journal of Psychopharmacology (Oxford, England)|May 12, 2022
Males and females differ in reported sexual functioning with escitalopram treatment for major depressive disorder: A CAN-BIND-1 study reportCaroline W Espinola, Yuelee Khoo, Roohie Parmar, et al.
Focus (American Psychiatric Publishing)|February 5, 2020
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine TreatmentsArun V Ravindran, Lynda G Balneaves, Guy Faulkner, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 4, 2016
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine TreatmentsArun V Ravindran, Lynda G Balneaves, Guy Faulkner, et al.
Molecular Psychiatry|November 21, 2019
Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studiesYun-He Wang, Jin-Qiao Li, Ju-Fang Shi, et al.
Bjpsych Open|January 5, 2024
Functional neuroimaging biomarkers of anhedonia response to escitalopram plus adjunct aripiprazole treatment for major depressive disorderSophie R Vaccarino, Shijing Wang, Sakina J Rizvi, et al.
Pageof 26

Showing results (221-230 of 252) with videos related to

Sort By:
Pageof 26
Psychiatry Research|May 10, 2023
The course of insomnia symptoms during the acute treatment of major depressive disorder: A CAN-BIND-1 reportManish Dama, Michelle Wu, Vanessa K Tassone, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 4, 2016
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 1. Disease Burden and Principles of CareRaymond W Lam, Diane McIntosh, JianLi Wang, et al.
Brain and Behavior|March 25, 2022
Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapyCaroline W Espinola, Yuelee Khoo, Roohie Parmar, et al.
BMJ Open|August 13, 2017
Comparative efficacy and acceptability of antidepressants, psychological interventions, and their combination for depressive disorder in children and adolescents: protocol for a network meta-analysisXinyu Zhou, Andrea Cipriani, Yuqing Zhang, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 4, 2016
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation TreatmentsRoumen V Milev, Peter Giacobbe, Sidney H Kennedy, et al.
Journal of Psychopharmacology (Oxford, England)|May 12, 2022
Males and females differ in reported sexual functioning with escitalopram treatment for major depressive disorder: A CAN-BIND-1 study reportCaroline W Espinola, Yuelee Khoo, Roohie Parmar, et al.
Focus (American Psychiatric Publishing)|February 5, 2020
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine TreatmentsArun V Ravindran, Lynda G Balneaves, Guy Faulkner, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 4, 2016
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine TreatmentsArun V Ravindran, Lynda G Balneaves, Guy Faulkner, et al.
Molecular Psychiatry|November 21, 2019
Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studiesYun-He Wang, Jin-Qiao Li, Ju-Fang Shi, et al.
Bjpsych Open|January 5, 2024
Functional neuroimaging biomarkers of anhedonia response to escitalopram plus adjunct aripiprazole treatment for major depressive disorderSophie R Vaccarino, Shijing Wang, Sakina J Rizvi, et al.
Pageof 26